<ARTICLE> 5 <LEGEND> This Schedule contains summary financial information extracted from the Form 10-QSB of Gish Biomedical, Inc., for the three months ended September 30, 2000 and is qualified in its entirety by reference to such financial statements. </LEGEND> <CIK> 0000700945 <NAME> GISH BIOMEDICAL, INC. <MULTIPLIER> 1000 <PERIOD-TYPE> 3-MOS <FISCAL-YEAR-END> JUN-30-2001 <PERIOD-START> JUL-01-2000 <PERIOD-END> SEP-30-2000 <CASH> 461 <SECURITIES> 685 <RECEIVABLES> 3,329 <ALLOWANCES> 171 <INVENTORY> 8,040 <CURRENT-ASSETS> 12,426 <PP&E> 9,673 <DEPRECIATION> 7,512 <TOTAL-ASSETS> 14,742 <CURRENT-LIABILITIES> 1,745 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 10,532 <OTHER-SE> 2,234 <TOTAL-LIABILITY-AND-EQUITY> 14,742 <SALES> 4,285 <TOTAL-REVENUES> 4,285 <CGS> 3,132 <TOTAL-COSTS> 1,704 <OTHER-EXPENSES> 0 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> (51) <INCOME-PRETAX> (500) <INCOME-TAX> 0 <INCOME-CONTINUING> (500) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (500) <EPS-BASIC> (.14) <EPS-DILUTED> (.14)